{"title":"绝经后雄激素过多症。","authors":"Rayhan A Lal, Marina Basina","doi":"10.4172/2167-0420.1000e132","DOIUrl":null,"url":null,"abstract":"Hirsutism is a fairly common diagnosis affecting 10% of women [1]. Mild symptoms are not always brought to medical attention, but severe cases, especially in menopause that are associated with hyperandrogenism, require evaluation and treatment. We present a case of postmenopausal hirsutism to demonstrate the diagnostic and therapeutic challenges seen in practice. A 55 year-old postmenopausal woman with history of multi nodular goiter, autoimmune hepatitis, lupus erythematosus panniculitis, diabetes and acid reflux presents with restlessness, increased libido, hair loss, worsening hirsutism, and 25-pound weight loss over 2 months. Medications include azathioprine, metformin, lisinopril, and omeprazole. Physical examination revealed BMI of 34 kg/m2, severe hirsutism (FerrimanGallwey score of 18), receding hairline, goiter, prior scarring from abdominal procedures and normal external genitalia without clitoromegaly. Labs included TSH 1.05 (normal 0.5-4.5), hemoglobin A1c of 6.1% (normal <5.7), LH 29.8 mIU/mL (normal 20-70), FSH 38.5 mIU/mL (normal 30-120), total testosterone 94.7 ng/dL (normal 7-40), free testosterone 2.2 ng/dL (normal <1), estradiol 28.5 pg/mL (normal <20), DHEA-S 25.2 μg/dL (normal 15-200), cortisol 7.1 μg/dL (normal 7-20) and ACTH 15 pg/mL (10-60 pg/mL). Screening tests for occult Cushing’s syndrome and pheochromoctyoma were negative.","PeriodicalId":17626,"journal":{"name":"Journal of Womens Health Care","volume":"7 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/33/c5/nihms-1055326.PMC7153778.pdf","citationCount":"4","resultStr":"{\"title\":\"Postmenopausal Hyperandrogenism.\",\"authors\":\"Rayhan A Lal, Marina Basina\",\"doi\":\"10.4172/2167-0420.1000e132\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Hirsutism is a fairly common diagnosis affecting 10% of women [1]. Mild symptoms are not always brought to medical attention, but severe cases, especially in menopause that are associated with hyperandrogenism, require evaluation and treatment. We present a case of postmenopausal hirsutism to demonstrate the diagnostic and therapeutic challenges seen in practice. A 55 year-old postmenopausal woman with history of multi nodular goiter, autoimmune hepatitis, lupus erythematosus panniculitis, diabetes and acid reflux presents with restlessness, increased libido, hair loss, worsening hirsutism, and 25-pound weight loss over 2 months. Medications include azathioprine, metformin, lisinopril, and omeprazole. Physical examination revealed BMI of 34 kg/m2, severe hirsutism (FerrimanGallwey score of 18), receding hairline, goiter, prior scarring from abdominal procedures and normal external genitalia without clitoromegaly. Labs included TSH 1.05 (normal 0.5-4.5), hemoglobin A1c of 6.1% (normal <5.7), LH 29.8 mIU/mL (normal 20-70), FSH 38.5 mIU/mL (normal 30-120), total testosterone 94.7 ng/dL (normal 7-40), free testosterone 2.2 ng/dL (normal <1), estradiol 28.5 pg/mL (normal <20), DHEA-S 25.2 μg/dL (normal 15-200), cortisol 7.1 μg/dL (normal 7-20) and ACTH 15 pg/mL (10-60 pg/mL). Screening tests for occult Cushing’s syndrome and pheochromoctyoma were negative.\",\"PeriodicalId\":17626,\"journal\":{\"name\":\"Journal of Womens Health Care\",\"volume\":\"7 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/33/c5/nihms-1055326.PMC7153778.pdf\",\"citationCount\":\"4\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Womens Health Care\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4172/2167-0420.1000e132\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2018/2/12 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Womens Health Care","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2167-0420.1000e132","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2018/2/12 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
Hirsutism is a fairly common diagnosis affecting 10% of women [1]. Mild symptoms are not always brought to medical attention, but severe cases, especially in menopause that are associated with hyperandrogenism, require evaluation and treatment. We present a case of postmenopausal hirsutism to demonstrate the diagnostic and therapeutic challenges seen in practice. A 55 year-old postmenopausal woman with history of multi nodular goiter, autoimmune hepatitis, lupus erythematosus panniculitis, diabetes and acid reflux presents with restlessness, increased libido, hair loss, worsening hirsutism, and 25-pound weight loss over 2 months. Medications include azathioprine, metformin, lisinopril, and omeprazole. Physical examination revealed BMI of 34 kg/m2, severe hirsutism (FerrimanGallwey score of 18), receding hairline, goiter, prior scarring from abdominal procedures and normal external genitalia without clitoromegaly. Labs included TSH 1.05 (normal 0.5-4.5), hemoglobin A1c of 6.1% (normal <5.7), LH 29.8 mIU/mL (normal 20-70), FSH 38.5 mIU/mL (normal 30-120), total testosterone 94.7 ng/dL (normal 7-40), free testosterone 2.2 ng/dL (normal <1), estradiol 28.5 pg/mL (normal <20), DHEA-S 25.2 μg/dL (normal 15-200), cortisol 7.1 μg/dL (normal 7-20) and ACTH 15 pg/mL (10-60 pg/mL). Screening tests for occult Cushing’s syndrome and pheochromoctyoma were negative.